You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
石藥集團(01093.HK):美沙拉秦腸溶片獲藥品註冊批件
格隆匯 07-04 18:25

格隆匯7月4日丨石藥集團(01093.HK)公吿,集團開發的美沙拉秦腸溶片(0.5g)("該產品")已獲得中華人民共和國國家藥品監督管理局頒發的藥品註冊批件,並視同通過仿製藥質量和療效一致性評價。

美沙拉秦主要通過調節引起腸道炎症黏膜的炎症相關指標來發揮其治療作用,可抑制引起炎症的前列腺素的合成及炎性遞質白三烯的形成,從而實現抗炎作用,其對有炎症的腸壁結締組織治療效果更佳。該產品適用於潰瘍性結腸炎的治療,包括急性發作期的治療和防止復發的維持期治療,以及適用於克羅恩病急性發作期的治療。該產品對腸壁的炎症有顯著的抑制作用,是全球廣泛使用的氨基水楊酸類抗炎藥。

該產品的獲批將進一步豐富集團在免疫系統治療領域的產品線。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account